77 related articles for article (PubMed ID: 1397675)
1. Combined zidovudine and interferon-alpha 2a therapy in children with acquired immune deficiency syndrome.
Giovannini M; Zuccotti GV; Biasucci G; Locatelli V; Riva E
J Int Med Res; 1992 Jun; 20(3):295-301. PubMed ID: 1397675
[TBL] [Abstract][Full Text] [Related]
2. A phase I study of recombinant human interferon-alpha 2a or human lymphoblastoid interferon-alpha n1 and concomitant zidovudine in patients with AIDS-related Kaposi's sarcoma.
Fischl MA; Uttamchandani RB; Resnick L; Agarwal R; Fletcher MA; Patrone-Reese J; Dearmas L; Chidekel J; McCann M; Myers M
J Acquir Immune Defic Syndr (1988); 1991; 4(1):1-10. PubMed ID: 1670585
[TBL] [Abstract][Full Text] [Related]
3. Zidovudine-interferon-alpha combination therapy in patients with advanced human immunodeficiency virus type 1 infection: biphasic response of p24 antigen and quantitative polymerase chain reaction.
Edlin BR; Weinstein RA; Whaling SM; Ou CY; Connolly PJ; Moore JL; Bitran JD
J Infect Dis; 1992 May; 165(5):793-8. PubMed ID: 1349031
[TBL] [Abstract][Full Text] [Related]
4. Interferon-alpha with zidovudine: safety, tolerance, and clinical and virologic effects in patients with Kaposi sarcoma associated with the acquired immunodeficiency syndrome (AIDS).
Krown SE; Gold JW; Niedzwiecki D; Bundow D; Flomenberg N; Gansbacher B; Brew BJ
Ann Intern Med; 1990 Jun; 112(11):812-21. PubMed ID: 1971504
[TBL] [Abstract][Full Text] [Related]
5. Low-dose interferon alpha combined with zidovudine in patients with AIDS-associated Kaposi's sarcoma.
Podzamczer D; Bolao F; Clotet B; García P; Casanova A; Pagerols X; Gudiol F
J Intern Med; 1993 Mar; 233(3):247-53. PubMed ID: 8095516
[TBL] [Abstract][Full Text] [Related]
6. Granulocyte-macrophage colony-stimulating factor mitigates the neutropenia of combined interferon alfa and zidovudine treatment of acquired immune deficiency syndrome-associated Kaposi's sarcoma.
Scadden DT; Bering HA; Levine JD; Bresnahan J; Evans L; Epstein C; Groopman JE
J Clin Oncol; 1991 May; 9(5):802-8. PubMed ID: 2016623
[TBL] [Abstract][Full Text] [Related]
7. Combination therapy with ZDV and interferon-alpha-2a promotes tumor regression.
J Int Assoc Physicians AIDS Care; 1996 Jun; 2(6):51. PubMed ID: 11363699
[TBL] [Abstract][Full Text] [Related]
8. Phase I trial of high-dose bolus interleukin-2 and interferon alfa-2a in patients with metastatic malignancy.
Budd GT; Murthy S; Finke J; Sergi J; Gibson V; Medendorp S; Barna B; Boyett J; Bukowski RM
J Clin Oncol; 1992 May; 10(5):804-9. PubMed ID: 1569452
[TBL] [Abstract][Full Text] [Related]
9. Low-dose zidovudine in combination with either acyclovir or lymphoblastoid interferon-alpha in asymptomatic HIV-infected patients: a pilot study.
Weber R; Bonetti A; Jost J; Vogt MW; Spacey B; Siegenthaler W; Lüthy R
Infection; 1991; 19(6):395-400. PubMed ID: 1816109
[TBL] [Abstract][Full Text] [Related]
10. Successful treatment of Kaposi's sarcoma with interferon-alpha in a patient with acquired immunodeficiency syndrome.
Yeh TS; Wang CR; Wong WW; Jeng GW; Chen MY; Liu CY; Chuang CY; Chen WY
Zhonghua Min Guo Wei Sheng Wu Ji Mian Yi Xue Za Zhi; 1993 Feb; 26(1):38-43. PubMed ID: 7907542
[TBL] [Abstract][Full Text] [Related]
11. Alpha interferon (2b) in combination with zidovudine for the treatment of presymptomatic feline leukemia virus-induced immunodeficiency syndrome.
Zeidner NS; Myles MH; Mathiason-DuBard CK; Dreitz MJ; Mullins JI; Hoover EA
Antimicrob Agents Chemother; 1990 Sep; 34(9):1749-56. PubMed ID: 2178336
[TBL] [Abstract][Full Text] [Related]
12. Phase I/II trials of alpha-interferon alone or in combination with zidovudine as maintenance therapy following induction chemotherapy in the treatment of acquired immunodeficiency syndrome-related Kaposi's sarcoma.
Gill PS
Semin Oncol; 1991 Oct; 18(5 Suppl 7):53-7. PubMed ID: 1719642
[TBL] [Abstract][Full Text] [Related]
13. A randomized trial of interferon-alpha2a and zidovudine versus bleomycin and zidovudine for AIDS-related Kaposi's sarcoma. Swiss HIV Cohort Study.
Opravil M; Hirschel B; Bucher HC; Lüthy R
Int J STD AIDS; 1999 Jun; 10(6):369-75. PubMed ID: 10414879
[TBL] [Abstract][Full Text] [Related]
14. Recombinant alpha-2a interferon treatment in patients with acquired immunodeficiency syndrome (AIDS) and AIDS-related complex (ARC): clinical and immunological evaluation.
Mezzaroma I; Avella A; Paganelli R; Ensoli B; d'Offizi G; Sirianni MC; Luzi G; Valdarchi C; Aiuti F
Allergol Immunopathol (Madr); 1991; 19(5):201-7. PubMed ID: 1811417
[TBL] [Abstract][Full Text] [Related]
15. A controlled trial of intravenous immune globulin for the prevention of serious bacterial infections in children receiving zidovudine for advanced human immunodeficiency virus infection. Pediatric AIDS Clinical Trials Group.
Spector SA; Gelber RD; McGrath N; Wara D; Barzilai A; Abrams E; Bryson YJ; Dankner WM; Livingston RA; Connor EM
N Engl J Med; 1994 Nov; 331(18):1181-7. PubMed ID: 7935655
[TBL] [Abstract][Full Text] [Related]
16. Interferon-alpha and zidovudine combination therapy for chronic hepatitis B: results of a randomized, placebo-controlled trial.
Janssen HL; Berk L; Heijtink RA; ten Kate FJ; Schalm SW
Hepatology; 1993 Mar; 17(3):383-8. PubMed ID: 8444411
[TBL] [Abstract][Full Text] [Related]
17. Synergy, activity and tolerability of zidovudine and interferon-alpha in patients with symptomatic HIV-1 infection: AIDS Clincal Trial Group 068.
Mildvan D; Bassiakos Y; Zucker ML; Hyslop N; Krown SE; Sacks HS; Zachary J; Paredes J; Fessel WJ; Rhame F; Kramer F; Fischl MA; Poiesz B; Wood K; Ruprecht RM; Kim J; Grossberg SE; Kasdan P; Bergé P; Marshak A; Pettinelli C
Antivir Ther; 1996 Apr; 1(2):77-88. PubMed ID: 11321183
[TBL] [Abstract][Full Text] [Related]
18. A phase I trial of interferon-alpha-2a plus cyclophosphamide, vincristine, prednisone, and doxorubicin.
Schiller JH; Hawkins MJ; O'Connell MJ; Sielaff K; Borden EC
J Biol Response Mod; 1989 Jun; 8(3):252-61. PubMed ID: 2746297
[TBL] [Abstract][Full Text] [Related]
19. Suppression of p24 antigen in sera from HIV-infected individuals with low-dose alpha-interferon and zidovudine: a pilot study.
Orholm M; Pedersen C; Mathiesen L; Dowd P; Nielsen JO
AIDS; 1989 Feb; 3(2):97-100. PubMed ID: 2496726
[TBL] [Abstract][Full Text] [Related]
20. Are there still indications for single agent high-dose interferon-alpha against AIDS-associated Kaposi's sarcoma?
de Wit R
Int J STD AIDS; 1992; 3(2):87-91. PubMed ID: 1571393
[No Abstract] [Full Text] [Related]
[Next] [New Search]
